129 related articles for article (PubMed ID: 15911988)
1. Preclinical testing of antileukemic drugs using an in vivo model of systemic disease.
Lock RB; Liem NL; Papa RA
Methods Mol Med; 2005; 111():323-34. PubMed ID: 15911988
[TBL] [Abstract][Full Text] [Related]
2. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
Dialynas DP; Shao L; Billman GF; Yu J
Stem Cells; 2001; 19(5):443-52. PubMed ID: 11553853
[TBL] [Abstract][Full Text] [Related]
3. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
[TBL] [Abstract][Full Text] [Related]
4. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
Dürig J; Ebeling P; Grabellus F; Sorg UR; Möllmann M; Schütt P; Göthert J; Sellmann L; Seeber S; Flasshove M; Dührsen U; Moritz T
Cancer Res; 2007 Sep; 67(18):8653-61. PubMed ID: 17875705
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
[TBL] [Abstract][Full Text] [Related]
6. Important role of caspase-8 for chemosensitivity of ALL cells.
Ehrhardt H; Wachter F; Maurer M; Stahnke K; Jeremias I
Clin Cancer Res; 2011 Dec; 17(24):7605-13. PubMed ID: 22010212
[TBL] [Abstract][Full Text] [Related]
7. The pediatric preclinical testing program: description of models and early testing results.
Houghton PJ; Morton CL; Tucker C; Payne D; Favours E; Cole C; Gorlick R; Kolb EA; Zhang W; Lock R; Carol H; Tajbakhsh M; Reynolds CP; Maris JM; Courtright J; Keir ST; Friedman HS; Stopford C; Zeidner J; Wu J; Liu T; Billups CA; Khan J; Ansher S; Zhang J; Smith MA
Pediatr Blood Cancer; 2007 Dec; 49(7):928-40. PubMed ID: 17066459
[TBL] [Abstract][Full Text] [Related]
8. JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
Uesato N; Fukui K; Maruhashi J; Tojo A; Tajima N
Exp Hematol; 2006 Oct; 34(10):1385-92. PubMed ID: 16982331
[TBL] [Abstract][Full Text] [Related]
9. Responses to donor lymphocyte infusion for acute lymphoblastic leukemia may be determined by both qualitative and quantitative limitations of antileukemic T-cell responses as observed in an animal model for human leukemia.
Nijmeijer BA; van Schie ML; Verzaal P; Willemze R; Falkenburg JH
Exp Hematol; 2005 Oct; 33(10):1172-81. PubMed ID: 16219539
[TBL] [Abstract][Full Text] [Related]
10. The thalidomide analogue, CC-4047, induces apoptosis signaling and growth arrest in childhood acute lymphoblastic leukemia cells in vitro and in vivo.
Shalapour S; Zelmer A; Pfau M; Moderegger E; Costa-Blechschmidt C; van Landeghem FK; Taube T; Fichtner I; Bührer C; Henze G; Seeger K; Wellmann S
Clin Cancer Res; 2006 Sep; 12(18):5526-32. PubMed ID: 17000689
[TBL] [Abstract][Full Text] [Related]
11. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a bioluminescent imaging-based in vivo leukemia model by intra-bone marrow injection.
Lee MW; Kim HJ; Yoo KH; Kim DS; Yang JM; Kim HR; Noh YH; Baek H; Kwon H; Son MH; Lee SH; Cheuh HW; Jung HL; Sung KW; Koo HH
Int J Oncol; 2012 Dec; 41(6):2047-56. PubMed ID: 23007607
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications.
Mitsiades CS; Mitsiades NS; Bronson RT; Chauhan D; Munshi N; Treon SP; Maxwell CA; Pilarski L; Hideshima T; Hoffman RM; Anderson KC
Cancer Res; 2003 Oct; 63(20):6689-96. PubMed ID: 14583463
[TBL] [Abstract][Full Text] [Related]
14. Xenografts of human hepatocellular carcinoma: a useful model for testing drugs.
Huynh H; Soo KC; Chow PK; Panasci L; Tran E
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4306-14. PubMed ID: 16857806
[TBL] [Abstract][Full Text] [Related]
15. A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenografts.
Ong V; Liem NL; Schmid MA; Verrills NM; Papa RA; Marshall GM; Mackenzie KL; Kavallaris M; Lock RB
J Pharmacol Exp Ther; 2008 Feb; 324(2):434-42. PubMed ID: 17986648
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
Uno S; Kinoshita Y; Azuma Y; Tsunenari T; Yoshimura Y; Iida S; Kikuchi Y; Yamada-Okabe H; Fukushima N
Oncol Rep; 2007 May; 17(5):1189-94. PubMed ID: 17390064
[TBL] [Abstract][Full Text] [Related]
17. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
18. Assessing growth and response to therapy in murine tumor models.
Reynolds CP; Sun BC; DeClerck YA; Moats RA
Methods Mol Med; 2005; 111():335-50. PubMed ID: 15911989
[TBL] [Abstract][Full Text] [Related]
19. The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
Carlo-Stella C; Di Nicola M; Turco MC; Cleris L; Lavazza C; Longoni P; Milanesi M; Magni M; Ammirante M; Leone A; Nagy Z; Gioffrè WR; Formelli F; Gianni AM
Cancer Res; 2006 Feb; 66(3):1799-808. PubMed ID: 16452241
[TBL] [Abstract][Full Text] [Related]
20. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice.
Ito R; Katano I; Kawai K; Hirata H; Ogura T; Kamisako T; Eto T; Ito M
Transplantation; 2009 Jun; 87(11):1654-8. PubMed ID: 19502956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]